News
A defensive tackle Gutekunst could target early in the draft is Tyleik Williams. The Ohio State defensive tackle checks in at ...
The global organ on a chip market was valued at US$ 157.06 million in 2024 and is expected to reach US$ 2,238.28 million by ...
Background Countries with resource-poor health systems have struggled to improve access to and the quality of caesarean section (C-section; CS) for women seeking care in public health facilities.
Technological advances empower the modification of NK cells and renewed potential for therapeutic uses in cancer and autoimmunity.
The U.S. Food and Drug Administration has approved a prefilled syringe version of Netherlands-based Argenx SE's blockbuster ...
A multi-institutional study led by Moffitt Cancer Center found that percutaneous hepatic perfusion using a melphalan hepatic ...
Tim-3 is an immune checkpoint molecule involved in immunity and inflammation recently linked to late-onset Alzheimer's disease (AD), but its role in the brain was unknown until now. Researchers used ...
The company has appointed Kotak Mahindra, Goldman Sachs and Morgan Stanley as lead managers for the offering. It is expected ...
During a live event, Benjamin Garmezy, MD, discussed combinations regimens used for patients with renal cell carcinoma after ...
Four leading companies CTMC, Iovance Therapeutics, KSQ, and TILT Biotherapeutics prognosticate coming successes of new technology approaches to better tumor-infiltrating lymphocyte activities.
A new technology for management of diabetes is cost-effective for patients in the US with type 1 diabetes compared with traditional treatments.
During a Case-Based Roundtable® event, John N. Allan, MD, discussed the addition of anti-CD20 antibody and the use of MRD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results